Wave intensity analysis (WIA) was used to delineate and maximize the efficacy of a newly developed para-aortic blood pump (PABP). The intra-aortic balloon pump (IABP) was employed as the comparison benchmark. Acute porcine experiments using eight pigs, randomly divided into IABP (n ϭ 4) and PABP (n ϭ 4) groups, were conducted to compare the characteristics of intra-and para-aortic counterpulsation. We measured pressure and velocity with probes installed in the left anterior descending coronary artery and aorta, during and without PABP assistance. Wave intensity for aortic and left coronary waves were derived from pressure and flow measurements with synchronization correction applied. To achieve maximized support efficacy, deflation timings ranging from 25 ms ahead of to 35 ms after the R-wave were tested. Similar to those associated with IABP counterpulsation, the PABP-generated backward-traveling waves predominantly drove aortic and coronary blood flows. However, in contrast with IABP counterpulsation, the nonocclusive nature of the PABP allowed systolic unloading to be delayed into early systole, which resulted in near elimination of coronary blood steal without diminution of systolic left ventricular ejection wave intensities. WIA can elucidate subtleties among different counterpulsatile support means with high sensitivity. Total accelerating wave intensity (TAWI), which was defined as the sum of the time integration of accelerated parts of the positive and negative wave intensities, was used to quantify counterpulsation efficacy. In general, the larger the TAWI gain, the better the counterpulsatile support efficacy. However, when PABP deflation timings were delayed to after the R-wave, the TAWI was found to be inversely correlated with coronary perfusion. In this delayed deflation timing setting, greater wave cancellation occurred, which led to decreased TAWI but increased coronary perfusion attributed to blood regurgitation reduction.
nisms behind diastolic augmentation and systolic unloading facilitated by the intra-aortic balloon pump (IABP) (13, 15) .
In the present research, WIA was applied to characterize the hemodynamic support supplied by a para-aortic blood pump (PABP). Para-aortic pumps operate on the same principle as IABP counterpulsation but are intended for long-term use to provide chronic contraction unloading and coronary perfusion augmentation (14) . Over the past 30 years, there have been studies documenting the superiority of the PABP versus IABP in animal and limited clinical trials (26) , but those studies have used traditional hemodynamic and metabolic indexes that are not able to decipher in detail the meaning underlying blood flow pulsatility. Thus, it is currently unclear how the paraaortic design of the PABP can be scrutinized to remedy the drawbacks and/or to improve the efficacy associated with IABP counterpulsation.
WIA is a tool that can be used to assess the performance of a pulsatile ventricular assist device design. WIA can differentiate and characterize pump-generated hemodynamic therapeutic functions at a much higher resolution than those deduced using typical indexes; it can interpret temporal events in the cardiac cycle directly in terms of energy carried by wave fronts on a beat-to-beat analysis and capture the dynamic interaction between the heart, the vasculature, and the counterpulsation device (1, 13, 15, 24) .
The objective of the present work was to apply WIA to 1) elucidate PABP counterpulsation performance characteristics and 2) explore design optimization strategy for paraaortic counterpulsation devices.
MATERIALS AND METHODS
Counterpulsatile support modalities. The present PABP device, which is made from polyurethane, is depicted in Fig. 1 . It consists of a T-manifold connected seamlessly on top of an oval-shaped diaphragm bladder. The T-manifold conduit and bladder assembly is housed within a semi-rigid outer shell on which a de-airing stub and a drive line are installed. The thin (3 mm diameter) drive line accepts pneumatically driven gases percutaneously, provided either by a bedside console or by a wearable driver. The present T-manifold is valveless and has a sharp-edged, compliant graft-host juncture design (14) . When anastomosed to the descending aorta with appropriate oversizing, the inserted manifold can snuggly be embraced by the lumen of the aortic wall. The stroke volume of this PABP is 40 ml, the same as the IABP balloon size presently used for comparison. Both IABP and PABP were driven by the same Datascope 98 XT console (Maquet Cardiovascular, Wayne, NJ) guided by the skin measured electrocardiogram (ECG) during experiments.
Animal model and instrumentation. The acute studies were performed on eight domestic Lanyu mini-pigs, weighing from 60 to 80 kg (mean, 67.4 Ϯ 2.7 kg). This study was approved by the Experimental Animal Committee of National Cheng Kung University Medical Center. The animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication no. 86-23, revised 1996) . These pigs were randomly divided into two study groups: IABP group (n ϭ 4) and PABP group (n ϭ 4).
Animals were premedicated by subcutaneous injection of the mixture of 6 mg/kg Zoletil plus 1.5 mg/kg Rompan and 0.02 mg/kg Atropine. Anesthesia was maintained using isoflurane in oxygen following endotracheal intubation. Left thoracotomy was performed at the 5th intercostal space with the 5th and 6th ribs removed to obtain chest access and to create space for the installation of measurement probes. The pericardium was incised, and a cradle was made to expose the heart. Cannulations were made in the left carotid artery and jugular vein to measure ascending aortic pressure (AoP) and central venous pressure, respectively; the right atrium apex to measure the right ventricular pressure; and the left atrium apex to measure the left ventricular pressure. The left anterior descending (LAD) coronary artery was dissected free for the coronary flow (CoF) measurement using a Transonic perivascular probe MA 2.5PSS (Transonic Systems, Ithaca, NY). Both aortic flow (AoF) and pulmonary flow rates were measured using the Transonic probes MA20PAX. The aortic flow probe was mounted on the ascending aorta immediately extending from the aortic root. The coronary flow rate was measured ϳ2 cm downstream of the LAD and circumflex branch juncture. Flow velocities in the aorta (AoU) and coronary artery (CoU) were obtained by dividing AoF or CoF by its corresponding cross-sectional area of the perivascular probe, respectively.
Data acquisition and filtering. All blood pressure measurements were obtained using a pressure transducer system DPT-248 (Utah Medical Products, West Midvale, UT). We transmitted all acquired pressure and flow rate data into a data acquisition (DAQ) card PCI-6229 (National Instrument, Austin, TX) driven by Labview (National Instrument) software system. Post-processing filter software available in Matlab (MathWorks, Natick, MA) was adopted to precondition the data. We used low-pass filtering to eliminate frequency content higher than 10 Hz so as to facilitate WIA and data presentation.
Calculation of wave intensity. We used the standard method for calculating wave intensity (19) . Briefly, the wave intensity (WI), or the energy of a wavelet sampled over an infinitesimal time period, is given by (12, 19) :
in which dP and dU are the pressure and velocity differences, respectively, measured over a small time interval defined presently to be dt ϭ 0.004 s. Both dP and dU, assumed as dP ϭ dP ϩ ϩ dPϪ and dU ϭ dUϩ ϩ dUϪ, consist of contributions associated with the forward (ϩ) and backward (Ϫ) wave modes. Waves can be forward or backward in wave propagation directions. In the aorta, forward flow is directed in the ejected blood direction from the heart to the periphery, whereas in coronary arteries forward flow (antegrade) direction is defined as going toward the coronary microcirculation. Furthermore, wave mode splitting can be determined using the measured pressure and velocity differences (12, 19) :
in which is the fluid density and c the wave speed. The intensities of the forward and backward waves can readily be deduced and expressed by (12, 19) :
Notice that wave intensity is always positive for the forward-going wave and negative for backward-going wave.
In the present study, the pressure and flow velocity waveforms required for evaluating WI were measured in vivo. A fluid-filled catheter inserted from the carotid artery was placed in the vicinity of the aortic root to measure AoP, where a Transonic perivascular flow probe was installed to measure AoF. However, for coronary WI derivation, we used AoP as a surrogate to represent LAD pressure. This special arrangement was adopted to avoid intravascular blockage interference created due to catheter insertion in LAD. It has been shown by the present authors using one-dimensional flow analysis that the dissipation and phase shift between pressure waveforms obtained at aortic root and LAD were small. The advantage of this approach lies in the assurance of CoF measurement fidelity, which is crucial for coronary augmentation evaluation. The phase shift committed in using AoP as coronary pressure surrogate, however, can be corrected by a synchronization procedure (14) .
Calculation of wave speed. The wave speed was identified using two methods, described in detail previously (15) . Briefly, the first method is the single-point technique (sum-of-squares) that has been used in the wave intensity analysis of coronary circulation in humans (7, 11, 24) and of the intra-aortic balloon pump in the porcine circulation (15) . Our second method is a model-based parameter identification method that was recently developed (15) . Advantages and limitations to both methods have been discussed previously; both methods give the same separation of waves and similar magnitude of WI peaks when applied to nondiseased arteries, as in the present study (15) .
Counterpulsation efficacy evaluation. Throughout the present comparison study, counterpulsatile support enforced by PABP was carried out in a 1:3 (1 pumping assistance per 3 heart beats) manner. The R-wave recognized on the ECG was taken as the initiation time of each beat cycle. For every three heart beats, diastolic augmentation and systolic unloading occurred over the diastolic and systolic phases pertaining to the first and the second beats, respectively; whereas the third beat was taken as the unassisted control beat. Counterpulsatile support effectiveness can thus be evaluated using data taken from the The strength of blood ejection or perfusion is directly proportional to the transported compression wave energy sent from upstream. Suction from downstream also has an equivalent effect in producing forward flow. This basic physical understanding motivated the present use of a newly defined total accelerating wave intensity (TAWI) to quantify enhancement in cardiac output and coronary perfusion. This integral sum TAWI, introduced as an overall energy index for evaluating counterpulsation efficacy, is herein defined by:
Physically, TAWI measures the overall pulse energy spent in pushing from upstream (the first term of Eq. 5a) or pulling from downstream (the second term of Eq. 5a) in the creation of a forward accelerated flow. In general, both forward compression and backward decompression wave intensities may contribute to TAWI.
Inflation/deflation timing definition. Inflation/deflation (or augmentation/unloading) timing has been found to be critical for maximizing counterpulsation performance (14, 21) . For the sake of convenience, we hereby define the temporal reference zero-point for inflation (augmentation) timing to be at the dicrotic notch. For deflation (unloading) timing, the temporal reference zero-point was defined to be at the R-wave. In the subsequent discussion we will use the notation (xx/yy ms) to represent device inflation at time xx after dicrotic notch and deflation at time yy after R-wave, both expressed in milliseconds.
In the following presentation we will use the term presystole deflation to signify the initiation of device unloading before the R-wave. We used postsystole deflation to signify the initiation of device unloading after the onset of R-wave. Figure 2 depicts the hemodynamic waveforms and WIs associated with the unassisted beats where the implanted PABP was turned off. Figure 2A illustrates the WI in aorta. Left ventricular (LV) contraction generates the strongest forward compression wave (C1) in early systole, whereas all the reflected waves are generally weak. Situated on the two sides of the dicrotic notch are two forward wave peaks; the former (D2) represents the decelerated decompression flow at late-systole before aortic valve closure, and the latter (C3) is caused by the compression wave generated due to sudden aortic valve closing. The timing of pump inflation may change the nearby D2 and/or C3 wave strengths.
RESULTS

WI characteristics of the unassisted control case.
Coronary waves of the unassisted case are shown in Fig. 2B . Major events including LV contraction/relaxation and the corresponding aortic pressurization/decompressurization are characterized by peaks shown on the coronary wave intensity traces. The prominent events are denoted by D1, C2, C3, D4, D5, and C6 (T ϭ 2.0ϳ2.7) on the plot. These waves have been previously found and investigated in animal (24, 25) and human (6, 7) experiments. In brief, the C2 peak has a small time lead ahead of C3 wave and represents the myocardial contraction-generated compression wave originated in the distal microcirculation. The C3 wave, however, arises in early systole as the strongest antegrade wave produced by the sudden aortic pressurization at the instant of aortic valve opening. The AoU, blood velocity in ascending aorta; CoU, blood velocity in left anterior descending coronary artery. Wave intensity dI is split into forward dIϩ and backward dIϪ components. Forward wave is defined in the blood ejection direction in aorta, and forward and backward wave directions are defined, respectively, in the antegrade and retrograde flow direction in coronary artery. In wave intensity plots, shaded areas indicate acceleration (dUϮ Ͼ 0) waves and hollow areas indicate deceleration (dUϮ Ͻ 0) waves. Label "C" represents compression wave, and "D" represents decompression wave; the numeric number signifies the occurrence sequence of the indicated wave.
suction D5 wave has been noted to correspond to the main perfusion force that sucks coronary blood from the aorta during early heart diastole (6). D1 and C3 waves are found closely related to LV unloading and the coronary regurgitation (blood steal) phenomenon, which influences counterpulsation performance (10, 14) . The C6 wave can be strengthened by pump augmentation right after aortic valve closure, constituting a simultaneous upstream compression and downstream suction mechanism that characterizes the salutary device-induced coronary perfusion augmentation of counterpulsation, as shown later.
IABP wave intensities. Figures 3 and 4 show the aortic pressure and flow rate measurements and the deduced WIs of a representative IABP-assisted subject. The results of IABP counterpulsation, enforced by standard inflation/deflation timing (0/Ϫ25 ms) and R-wave deflation (0/0 ms), were reported previously (14) and now reproduced into Figs. 3 and 4 so as to ease the comparison with PABP counterpulsation and wave intensities.
It is seen in the aortic WI plots that backward waves marked by "Aug" and "Unl" are IABP-generated due to balloon inflation (augmentation) and deflation (unloading), respectively. When comparing Figs. 3 and 4, the unloading effect exerted by these closely timed balloon deflations exhibits drastic changes in WI patterns due to a mere 25-ms deflation delay. Presystolic balloon deflation (Fig. 3) resulted in low end-diastolic aortic pressure, coronary blood flow regurgitation (the dip in CoU profile upon balloon deflation), enhanced LV ejection, and increased device-induced WI strengths in both aorta and coronary bed during contraction unloading. However, for the R-wave balloon deflation case (Fig. 4) , both aortic and coronary WIs diminish significantly upon balloon deflation, indicating impaired unloading and impeded LV ejection, but reduced coronary regurgitation. It is observed that WIs in the aorta and coronary artery are sensitive indicators in relation to the deflation timing control of IABP. A small 25-ms deflation delay reduced systolic intensities by 40% and decreased the unloading suction intensity by as much as 67%.
PABP wave intensities. Figures 5, 6 , and 7 show the pressure and flow rate measurements and the deduced WIs of a representative PABP-assisted subject using three inflation/deflation control settings: (0/Ϫ25 ms), (0/0 ms), and (0/25 ms). The former two Fig. 3 . Hemodynamic and WI characteristics of the intraaortic balloon counterpulsation enforced using (0/Ϫ25 ms) timing setting (inflated on dicrotic notch and deflated 25 ms before R-wave). Cardiac output (CO) ϭ 2.59 l/min, and coronary perfusion (CoPerf) ϭ 43.6 ml/min. A: aortic (AoP) and drive-line pressure (DP) waveforms; Inf, inflation; Def, deflation, indicating the inflation/deflation event appearing on the DP waveform trace. Vertical lines passing through Inf and Def points indicate the initiation time of pumping augmentation and unloading, respectively. B: blood velocities in the ascending aorta (AoU) and left anterior descending coronary artery (CoU). C: aortic wave intensities. Forward, dIϩ; backward, dIϪ. Forward wave is defined in the blood ejection direction. D: coronary wave intensities. Forward, dIϩ; backward: dIϪ. Forward and backward wave directions are defined, respectively, in the antegrade and retrograde flow direction in coronary artery. In wave intensity plots, shaded areas indicate acceleration (dUϮ Ͼ 0) waves and hollow areas indicate deceleration (dUϮ Ͻ 0) waves. Abbreviations marked on C and D are wave events with major counterpulsation significance: "Aug" and "Unl" represent waves generated by "unloading" or "augmentation" actions, respectively. IABP, intra-aortic balloon pump.
timings can be compared with IABP counterpulsation and the last represents a new postsystole unloading scenario.
The WIA of diastolic augmentation and systolic unloading provided by the PABP is illustrated in the first and second beats of Figs. 5 to 7. The (0/Ϫ25 ms) PABP setting (Fig. 5) is the same as the standard IABP control setting-deflation at one count (25 ms) before the R-wave (before the onset of ventricular ejection). Figures 6 and 7 show the aortic and LAD coronary wave intensities during PABP counterpulsation with delayed deflation timings.
Delaying the PABP deflation timing did not have a detrimental effect on systolic ejection. The aortic systolic compression wave intensity dI ϩ (T ϭ 1.1ϳ1.2; Figs. 6C and 7C) had approximately the same strength as that of the unassisted beat. However, delayed PABP deflation timing did affect coronary wave intensity. The coronary waves (T ϭ 1.0 ϳ 1.2; Figs. 6D and 7D) were decreased in overall intensity due to substantial wave cancellation; the wave intensities from the pump unloading and the LV systole cancelled each other.
Inflation/deflation control effect. For both IABP and PABP counterpulsations, it has been shown that inflation at aortic valve closure (dicrotic notch) leads to the largest coronary perfusion assistance (14, 21) . Hence, in the search of optimal PABP counterpulsation, we fixed pump inflation at the dicrotic notch and varied the deflation timing only. Figure 8 shows the effect of different deflation timings on the hemodynamic characteristics and WIs of the PABP in a porcine subject, from 25 ms before to 25 ms after the R-wave. Aortic WI remains literally invariant, whereas coronary perfusion and WI undergo substantial changes. The cancellation phenomenon of unloading and LV systolic waves becomes prominent when pump deflation overlaps more with systolic ejection, as revealed in the coronary velocity (CoU) and WI waveforms.
TAWI gain and counterpulsation efficacy. The relationship between TAWI and counterpulsation support efficacy is shown in Fig. 9 for the four pigs assisted by (0/0 ms) or (0/Ϫ25 ms) timed PABP counterpulsation. These results show PABP counterpulsation associated with presystole deflation timing. Although the subject number (n ϭ 4) is small, a strong positive correlation was found between TAWI and cardiac output and between TAWI and coronary perfusion augmentation. In pig No. 8 we experimented with different deflation timings from presystole to postsystole deflation timing (Ϫ25, 0, 25, and 35 ms). The results are shown in Fig. 10 . We found that coronary perfusion augmentation was inversely correlated with TAWI. Contrary with the general findings revealed in Fig.  9 , when a delayed postsystole PABP deflation strategy was performed, a diminished TAWI was associated with improved coronary perfusion.
DISCUSSION
In the present study, we introduced WIA to assess the counterpulsation performance of the PABP. We have demonstrated how WIA can be used to identify and quantify the predominating aortic and coronary arterial waves in counterpulsation. It is shown presently that the waves were sensitive to inflation/deflation timing and that a proper deflation timing design of PABP led to reduced coronary regurgitation and increased coronary perfusion without impairing the systolic ejection flow and the associated aortic wave intensity.
PABP deflation design. The primary effect of delayed deflation settings is that of reduced coronary regurgitation or coronary blood steal. Delayed timings led to weaker forward decompression unloading waves compared with that of the presystole IABP deflation setting (0/Ϫ25 ms). This weaker unloading wave led to reduced coronary regurgitation at time of systolic unloading, as shown in the CoU curves (Fig. 8B) . There was a lesser dip in the coronary flow velocity at delayed timings. These findings demonstrate that when compared with presystole unloading, there was a weaker suction power pulling the blood out of the coronary circulation at the delayed timing, leading to less coronary regurgitation at further delayed timings as shown in Fig. 8 . Meanwhile, the rightward-shift of the unloading wave at delayed timings also indicates a prolonged diastolic perfusion period favoring myocardial perfusion.
Push-pull effect of delayed deflation timing. Presystole deflation timing leads to a consecutive pull-push phenomenon. Initially, there is an afterload decrease-a pull-from the suction effect of pump deflation that is characteristic of systolic unloading, seen as an initial decrease in aortic pressure, which is accompanied by a presystolic blood ejection hump (Tϳ0.9 -1.1, flow velocity AoU in the aorta; Fig. 5B ) and a prolonged ejection phase. This hump signifies a premature aortic valve opening attributed to the pump-induced unloading suction effect. The pull is followed by the push from left ventricular contraction, seen as an initial increase in the aortic pressure. This push is then followed by a second rise in the aortic pressure (from T ϳ1.23 to T ϳ1.3; Fig. 5A ) because there is a decrease in the reduction of aortic pressure from PABP systolic unloading during middle-to-late systole.
Delayed deflation timing has a push-pull effect. The pushing effect of ventricular contraction is followed closely by and overlaps maximally with the pulling effect from PABP deflation. With delayed deflation timings, there is a reduced second rise in aortic pressure because the PABP suction effect continues for a longer period of time into middle-to-late systole. As the deflation timing is increasingly delayed, there is a progressively reduced second rise in aortic pressure. The net effect of delaying pump deflation into LV systole is that the afterload reduction occurs later in systole and there is a faster decline of aortic pressures during mid-to-late systole, which corresponds to an increase in aortic blood flow velocity compared with the presystole deflation timing. This explains why delaying the PABP deflation does not detrimentally reduce the forward systolic compression wave intensity during systolic ejection; delayed unloading helps contraction and ejection by pulling flow out of the ventricle. Correspondingly, the aortic flow velocity increases and the overall cardiac output performance does not diminish at delayed deflation settings (14) .
Because deflation timing is delayed step-wise, there is progressively reduced aortic pressure drops during systolic unloading. For example, at presystole (0/Ϫ25 ms) deflation timing, the aortic pressure drops to as low as 20 mmHg during systolic unloading. When deflation timing is delayed to 25 ms after the R-wave, the aortic pressure only mildly decreases to 50 mmHg. Despite the lowered afterload reduction, there is not a sacrifice in the ejected flow and wave intensity. The push-pull effect explains why, at delayed timings, despite the decrease in initial aortic pressure drop, the PABP can reduce LV stroke work and increase the endocardial viability ratio while decreasing coronary regurgitation and maintaining the strength of LV ejection (14) .
Differences between IABP versus PABP performance. IABP unloading is restrictive because late postsystole balloon deflation would increase the afterload, which would then impair LV Fig. 6 . Hemodynamic and WI characteristics of the paraaortic blood pump counterpulsation implemented using (0/0 ms) timing setting (inflated on dicrotic notch and deflated on R-wave). CO ϭ 2.91 l/min, and CoPerf ϭ 27.5 ml/min. See ejection. This intra-aortic balloon placement renders coronary blood steal an unavoidable cost for achieving LV unloading. This characteristic is clearly reflected in the WI changes shown in Figs. 3 and 4 .
In contrast, PABP deflation could be delayed without detriment to the LV systolic compression WI sent downstream the aorta. This illustrates the nonocclusiveness advantage of PABP. Unlike the IABP, the PABP is placed outside of the aorta; thus there is no initial afterload increase at delayed deflation settings. At delayed timing, the PABP can reduce coronary regurgitation and achieve a net increase in coronary perfusion (14) without diminishing systolic unloading effect and without decreasing systolic ejection wave intensities and cardiac output in the aorta.
Pulse wave energy transport and counterpulsation efficacy. Traditionally, systolic unloading and diastolic augmentation are measured in terms of the decrease in end-diastolic pressure and the elevation of peak diastolic AoP, respectively. These pressure variations could be misleading when used to interpret counterpulsation efficacy (14) . The present proposition of using TAWI has its roots in pulse wave energy transport theory and, in particular, emphasizes the importance of analyzing perfusion-assisting waves (dU Ϯ Ͼ 0). Notice that contributing factors, including device design, intra-or para-aortic placement, and inflation/deflation timing, all affect TAWI. We thereby hypothesize that a better counterpulsatile device design should produce higher TAWI to achieve more forward flow enhancement in the aorta and coronary bed.
The results shown in Fig. 9 support the use of TAWI as an energy index to quantify cardiac output and coronary perfusion. A strong correlation between TAWI and cardiac output and coronary perfusion depicted in Fig. 9 suggests that TAWI is an appropriate energy index to quantify the unloading and augmentation effectiveness of counterpulsation, if presystole deflation timings are used.
When postsystole deflation timings were used, there was an inverse relationship between coronary perfusion (CoPerf) and TAWI increase (Fig. 10) . During postsystole deflation timings, wave cancellation occurs; the LV compression wave and the PABP suction decompression wave overlap and annihilate each other. The ability of the PABP suction wave to suck blood out of the coronary circulation is decreased by the LV com- pression wave that directly cancels the PABP suction wave; this cancellation occurs to varying degrees, depending on the extent of delay in deflation timing. The wave cancellation seen in the postsystole deflation timings becomes evident when examining the coronary artery wave intensities. In the coronary artery, coalescence of LV compression and PABP decompression waves resulted in a net decrease in coronary wave intensity (Fig. 8D) . This wave cancellation became more pronounced as the postsystole deflation timing was increasingly delayed.
Because coronary wave intensities progressively decreased as deflation timing was delayed further beyond the R-wave, and the TAWI calculation accounts for coronary wave intensities, TAWI decreased progressively as well. However, as demonstrated above, coronary perfusion is increased in postsystole deflation timing. This explains why reduced TAWI was found to be correlated with enhanced coronary perfusion as seen in Fig. 10 .
Clinical relevance. Currently, continuous-flow LV devices are dominating the field of circulatory support (4). However, continuous-flow LVADs are not without drawbacks. The cannulation of these LVADs have often been operated via apical coring, frequently resulting in excessive LV unloading and myocardial atrophy (2) . The nonpulsatile assist may also induce vasoconstriction in small vessels, increase systemic vascular resistance, and reduce vascular reactivity, making perfusion augmentation in microcirculation less efficient (27) . Furthermore, these LVADs are expensive and require cardiopulmonary bypass and long-term anticoagulation therapy (4).
A small, but growing body of literature show that newer long-term, partial-support counterpulsation devices, such as the para-aortic pump devices, have several theoretical advantages over conventional LVADs. Counterpulsation devices are less traumatic to recipients and simpler to implant (usually not requiring cardiopulmonary bypass) (5, 9, 10, 14, 16, 17, 23, 29) and are far less costly (by up to 40 times) than conventional LVADs (4). Moreover, unlike LVADs, they avoid injury to the heart and often require no or minimal anticoagulation (9, 10, 14) . These advantages enable long-term counterpulsation devices to be used earlier in the moderate-to-severe stages of heart failure, which, in principle, may break the vicious cycle of myocardial deterioration and achieve the benefit of possible myocardial reverse remodeling and recovery (2, 8) .
Furthermore, studies show that when compared with the IABP, these long-term counterpulsation devices have 1) greater diastolic augmentation and more efficient reduction of LV contraction afterload (14, 26, 29) ; 2) restored hemodynamics even in the presence of severe cardiogenic shock in both experimental and human settings (17, 24) ; and 3) offered longer counter-pulsatile therapy because these devices offer patient mobility and longterm use (9, 26) .
However, studies that show design superiority of these counterpulsation devices over the IABP rely on traditional hemodyamic indexes (e.g., reduction of end-diastolic aortic pressure) or metabolic indexes (e.g., tension time index or endocardial viability ratio). These traditional indexes do not offer a sufficiently high-resolution to characterize and quantify counterpulsation effectiveness from a mechanistic standpoint. Our study demonstrates how WIA can be applied to scrutinize the design of a pulsatile ventricular assist device and to evaluate the superiority of a device design over another using information implied in hemodynamic waveforms. Differences in counterpulsation therapeutics, as revealed by WIA, may become particularly significant when the device support is applied long-term in a patient; incremental improvements in augmentation of coronary flow with each beat may accrue to have significant long-term benefit.
Study limitations. The acute animal experiments performed presently required left thoracotomy with two ribs removed, pericardium dissected, and arteries freed from the connecting tissues. This surgical setting contributed to dilation of the heart and increased vessel compliance. In addition, anesthesia contributed to vasodilation. The open chest contributed to low aortic pressure, flattened diastolic decay, and diminished coronary suction waves, a phenomenon that mimics advanced heart failure. Previous studies conclude that counterpulsation support is less effective when aortic systolic pressure is low (Ͻ60 or 70 mmHg) (3, 18, 28) . Increased large vessel compliance may also jeopardize counterpulsation efficacy (3, 18) .
PABP efficacy may have been underestimated in the present study because in the postoperative patient, recipients of the procedure would have closed chests and higher aortic pressures (in contrast with the acute experimental setting). Effectiveness of PABP counterpulsation in the closed-chest patient with normotensive blood pressures needs further studying.
The present 1:3 support mode is not the one most frequently used clinically. The advantage of the 1:3 mode lies in the robustness of evaluating counterpulsation effectiveness. The effects of anesthesia, individual responses to open chest surgery, autoregulation etc., can be temporarily isolated from the device efficacy evaluation. The authors also performed mock loop tests on this PABP using 1:1, 1:2, and 1:3 modes. The support efficacy was best seen with the 1:1 mode and the least for 1:3 mode. The results observed from the present 1:3 support mode can be extrapolated to other support modes, but future in vivo investigations are still required to test the true support effectiveness in different modes.
In WIA, pressure and flow velocity measurements should, in principle, be coincident in space and synchronous in time. The present coronary pressure was not directly measured but replaced by the ascending aortic pressure as a surrogate marker. The state-of-the-art intravascular pressure or flow wires are still thick compared with the LAD lumen size (22) . Substantial blockage interference (Ͼ50% of the vessel cross-sectional area) would be incurred using intravascular sensors and the results, in particular the flow rate, would be inaccurate. The present WI calculation method is believed to be appropriate, albeit not perfect. Whether this pressure surrogate approach can be accepted formally in coronary WIA awaits future theoretical or computational studies.
The present interpretation of wave energy in the aorta and in the coronary artery with regard to counterpulsation is based mainly on wave mechanics and further supported by limited animal experiments (n ϭ 4). Future investigations with a larger subject population are required to validate the TAWI proposition.
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